SMXT

SMXT's headline is a 295.8% revenue jump to $91.0M, but the filing makes clear this is not a healthy growth story — it's a company fighting for survival. Management's own 10-K carries a going-concern footnote and discloses a $20.4M working capital deficit against just $8.0M of cash. The balance sheet is already underwater: stockholders' equity is -$12.2M with a -$110M accumulated deficit, so liabilities/equity is meaningless (-8.48x). Most damningly, the company is in default on $14.3M of convertible notes, owes $5.5M to a related party and $2.5M to its own CEO, and has received a Nasdaq notice for trading below $1.00 — the stock is at $0.35. Any of these can force acceleration, a dilutive raise, or delisting.

The revenue quality is thin and dangerously concentrated. Of FY2025 revenue, $60.2M (66.1%) came from a single Texas BESS contract with Longfellow, all booked in H2 2025, and $56.6M of accounts payable relates to that one contract. Gross margin is just 4.6% and operating margin is -6.9%, so even at nearly 4x revenue the business does not cover its own overhead. Management explicitly warns these are fixed-price contracts, that the first BESS system is not yet complete, that the three new Dec-31-2025 contracts have not started, and that it cannot assure any gross profit — this is an unproven pivot, not a track record.